Refine
Document Type
- Doctoral Thesis (3)
Language
- English (3)
Has Fulltext
- yes (3)
Is part of the Bibliography
- no (3)
Keywords
- Mitochondrial protein import (1)
- Mitophagy (1)
- PAM-complex (1)
Institute
- Medizin (2)
- Biochemie und Chemie (1)
Correct cellular function is ensured by a complex network of proteins and enzymes, regulating protein synthesis and degradation. This protein network, maintaining the so-called protein homeostasis, regulates those processes on multiple levels, producing new or degrading old proteins to cope with changing intra- and extracellular environments. Disturbance of this tightly regulated machinery can have severe effects on the cell and can lead to a variety of pathologies on organism level. Diseases including cancer, neurodegeneration and infections are associated with causative or consequent alterations in protein homeostasis. To understand the pathologies of these diseases, it is therefore critical to examine how perturbations of protein homeostasis affect cellular pathways and physiology. In the recent years, analysis of protein homeostasis networks has resulted in the development of novel therapeutic approaches. However, for many factors it remains unclear how the cell is affected, if they are disturbed. Protein synthesis and degradation represent immediate responses of the cell to changes and need to be studied in the right timeframe, making them difficult to access by common methodology. In this work we developed a new mass spectrometry (MS) based method to study protein synthesis and degradation on a system-wide scale. Multiplexed enhanced protein dynamic (mePROD) MS was developed, overcoming these limitations by special sample mixing and novel data analysis protocols. MePROD thereby enables the measurement of rapid and transient (e.g. minutes) changes in protein synthesis of thousands of proteins. During responses of the cell to stressors (e.g. protein misfolding, oxidation or infection), two major pathways regulate the protein synthesis: the Integrated Stress Response (ISR) and mammalian target of rapamycin (mTOR). Both pathways have been connected with various diseases in the past and are common therapy targets. Although both pathways target protein synthesis in stress responses, the set of targets regulated by these pathways was believed to differ. Through the new mePROD MS method we could measure a comprehensive comparison of both pathways for the first time, revealing comparable system-wide patterns of regulation between the two pathways. This changed the current view on the regulation elicited by these pathways and furthermore represents a useful resource for the whole field of research. We could further develop the mePROD method and decrease MS measurement time needed to obtain an in-depth dataset. Through implementation of logic based instrument methods, it was possible to enhance the number of measured proteins by approximately three-fold within the same measurement time.
The dynamics of protein synthesis and degradation are frequently modulated by pathogens infecting the cell to promote pathogen replication. At the same time, the cell counteracts the infection by modulating protein dynamics as well. To develop useful therapy approaches to fight infections, it therefore is necessary to understand the complex changes within the host cell during infections on a system-wide scale. In 2019, a novel coronavirus spread around the world, causing a world-wide health-crisis. To better understand this novel virus and its infection of the host cell we conducted a study applying the mePROD methodology and classical proteomics to characterize the dynamic changes during the infection course in vitro. We discovered that the infection remodeled a diverse set of host cell pathways (e.g. mRNA splicing, glycolysis, DNA synthesis and protein homeostasis) and thereby showed possible targets for antiviral therapy. By targeted inhibition of these pathways, we could observe that these pathways indeed are necessary for SARS-CoV-2 replication and their inhibition could reduce viral load in the cells. Another experimental approach focused on the dynamic changes of protein modification, namely phosphorylation, after infection with SARS-CoV-2. Here, we could show the very important participation of growth factor signaling pathways in viral proliferation. Both studies together revealed critical pathways that are needed for the viral proliferation and hence are promising candidates for further therapies. Subsequent targeting of these pathways by either already approved drugs (Ribavirin and Sorafenib) or drugs in clinical trials (2-deoxyglucose, Pladienolide-B, NMS-873, Pictilisib, Omipalisib, RO5126766 and Lonafarnib) could block viral replication in vitro and suggests important clinical approaches targeting SARS-COV-2 infection.
Mitochondria are important for cellular health and their dysfunction is linked to a variety of diseases, especially neurodegeneration. Thus, the renewal and degradation of dysfunctional mitochondria is crucial for the well-being of organisms. The selective digestion of damaged mitochondria via the lysosome (mitophagy), is the main pathway to do so.
In my dissertational work, I investigated the connection between protein misfolding, protein import into mitochondria and the degradation of mitochondria via mitophagy. Here, I present a new model for the initiation of mitophagy without collapse of the membrane potential. This model provides the link between protein import into mitochondria, stress signal transduction to the cytosol and the mitochondrial stress sensor PINK1. To comprehensively examine how mitophagy can be triggered, I performed a genome-wide CRISPR knockout screen utilizing the mitophagy reporter mitochondrial mKEIMA. Thereby, I observed numerous novel gene deletions that induce mitophagy. Prominently, I identified an accumulation of gene deletions of the protein import and of protein quality control factors. I validated several of those and examined HSPA9 (mitochondrial HSP70) and LONP1 (a mitochondrial matrix AAA protease) in more detail, regarding their effect on mitophagy and protein import. For this, I used an established fluorescence-based, mitochondrial-targeted EGFP, as well as a newly-developed pulsed-SILAC mass spectrometry approach (mePRODmt). Depletions of both genes resulted in reduced protein import and PINK1-dependent mitophagy. Strikingly, I did not observe any loss of mitochondrial membrane potential, which was hitherto believed to be essential for activation of PINK1-mediated mitophagy. Literature shows that certain mitochondrial stressors can also induce mitophagy without mitochondrial membrane depolarization, which I confirmed with my assays. Next, I characterized the impact of LONP1 and HSPA9 depletion, which are involved in proteostasis maintenance, and the mtHSP90 inhibitor GTPP on mitochondrial protein folding in more detail. GTPP treatment and LONP1 depletion both resulted in the accumulation of an insoluble protein fraction, as judged by proteomic analysis. This insoluble protein fraction enriched several components of the presequence translocase-associated motor PAM, including TIMM44. TIMM44 acts as a link between the translocon, the import pore of the inner mitochondrial membrane (TIM) complex and the PAM complex. Thus, I hypothesized that TIMM44 dissociates from the TIM complex upon protein folding stress, when it becomes part of the insoluble protein fraction. To validate this model, I measured the TIMM44 interactome upon proteostasis disturbance using proximity labeling. Indeed, interaction of TIMM44 with the import pore was almost completely abolished, explaining the loss of matrix-targeted import upon protein folding stress. From these findings, I reasoned that an import reduction mediated by the PAM complex would likely also inhibit the degradation of PINK1. Consistent with this hypothesis, I observed that mitophagy induced by HSPA9 or LONP1 deletion was prevented when PINK1 was genetically deleted. In comparison, non-processed PINK1 was stabilized on mitochondria in wild type cells when mitochondrial protein import was impaired. On this basis, I drew the conclusion that the loss of mitochondrial import was the stress signal, which leads to the stabilization of PINK1, as it could not be processed anymore via the inner mitochondrial membrane protease PARL. PINK1 auto-activates itself upon accumulation and signals to the cytosol that this mitochondrion is damaged. Mitophagy is subsequently initiated by the ubiquitin kinase activity of PINK1. As a result, the autophagy apparatus gets activated, damaged mitochondria are engulfed by a double membrane and removed via lysosomal digestion. This proposed model is, to the best of my knowledge, the first to provide an explanation for protein folding stress-induced and protein import inhibition-triggered mitophagy without mitochondrial depolarization. The model thus extends the PINK1/PARKIN-dependent mitophagy pathway to milder stresses and clears some of the open questions in the field. Furthermore, this work is also important, because protein misfolding stress and dysfunctional mitochondria are two hallmarks of neurodegeneration. In particular, mitochondrial protein import inhibition during Parkinson’s and Huntington disease might be driver of mitochondrial dysfunction. Hence, I hope and anticipate that the newly developed protein import method, mePRODmt, and the proposed model will be beneficial to further characterize underlying processes and to establish which factors prevent or drive these disorders on molecular level.
Mitochondrial RNA granules (MRGs) are membraneless, highly specialized compartments that play an essential role in the post-transcriptional regulation of mitochondrial gene expression. This regulation is crucial for maintaining energy production, controlling metabolic functions and ensuring homeostasis in cells. Dysregulation of mitochondrial genes has been linked to various human diseases, including neurodegenerative and metabolic disorders as well as certain types of cancer.
MRGs are composed of different RNA species, including mitochondrial precursor RNA (pre-RNA), mature tRNAs, rRNAs and mRNAs complexed with multiple proteins involved in RNA processing and mitoribosome assembly. However, despite the significance of MRGs, their protein composition, structural organization, stability and dynamics during stress conditions remain elusive. In the study reported here, I adopted a three-step approach to address the aforementioned fundamental issues.
First and foremost, I identified the protein composition of MRGs and unveiled their architectural complexity. To characterize the MRG proteome, I applied the cutting-edge TurboID-based proximity labeling approach combined with quantitative mass spectrometry. Proximity labeling was conducted on 20 distinct MRG-associated human proteins, resulting in the identification of more than 1,700 protein-protein interactions. This expansive dataset enabled me to create a comprehensive network, providing valuable insights into both the (sub)architecture as well as the core structure of MRGs in-depth.
Secondly, I investigated the spatio-temporal dynamics of MRGs under various mitochondrial stress conditions. To monitor the morphological alterations and compositional changes of MRGs, I utilized time-resolved confocal fluorescence microscopy and proteomics, respectively. In this analysis, I applied IMT1, the first specific inhibitor that selectively targets mitochondrial transcription. Using this methodology, I pinpointed precise conditions that triggered MRGs’ disassembly during stress, followed by their reassembly when nascent RNA production was restored. The results of this examination elucidate that MRGs are highly dynamic and stress adaptive structures, capable of rapid dissolution and reassembly, a process closely connected to mitochondrial transcription.
Thirdly, I aimed to explore the impact of RNA turnover on MRGs’ integrity during stress, employing confocal fluorescence microscopy and quantitative real-time PCR. I observed that depletion of MRG proteins associated with RNA degradation counteracts MRGs’ disassembly under stress conditions, a phenomenon attributed to the accumulation of double-stranded RNA (dsRNA). These results emphasize the critical role of pre-RNA turnover in maintaining MRG integrity and reveal that MRGs can be stabilized by dsRNA.
Taken together, the comprehensive investigation reported in this thesis has substantially broadened and deepened our understanding of MRGs’ complexity. By identifying their molecular structure and dynamics, I have gained significant insights into the fundamental characteristics and biological functions of MRGs in cellular processes. This knowledge contributes to the identification of disease-related pathways linked to mitochondrial gene expression and may inspire future studies to develop novel therapeutic approaches.